STAAR Surgical Company (STAA)
Official siteHEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NASDAQ
Market Cap: $1.32B
Last updated: Nov 17, 2026 at 4:10 PM ET
STAAR Surgical Company (STAA) Stock Chart
STAAR Surgical Company (STAA) has a latest price of $25.56 on Nov 17, 2026, 28.7% below its 52-week high of $35.87. Its price fell 2.9% over the past 12 months. The month-end price rose 190.4% over the 10 years through Oct 2026, a compound annual rate of 11.3%.
Price Chart
From Oct 2016 to Oct 2026, its highest month-end close was $154.47 in Aug 2021 and its lowest $8.45 in Oct 2016, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart STAA with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for STAA.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price rose 3.6%, and over 6 months it fell 21.6%. The month-end price fell 41.3% over the 3 years through Oct 2026, a compound annual decline of 16.3%.
| Period | Change |
|---|---|
| 1 month | +16.8% |
| 3 months | +3.6% |
| 6 months | -21.6% |
| 12 months | -2.9% |
| 12 months, with dividends | -2.9% |
| Period | Change | Per year |
|---|---|---|
| 3 years | -41.3% | -16.3% |
| 5 years | -79.3% | -27.0% |
| 10 years | +190.4% | +11.3% |
Price by Year
Its best calendar year was 2020, when the price rose 125.2%, and its weakest was 2022, when it fell 46.8%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $24.54 | +6.3% |
| 2025 | $23.09 | -4.9% |
| 2024 | $24.29 | -22.2% |
| 2023 | $31.21 | -35.7% |
| 2022 | $48.54 | -46.8% |
| 2021 | $91.30 | +15.2% |
| 2020 | $79.22 | +125.2% |
| 2019 | $35.17 | +10.2% |
| 2018 | $31.91 | +105.9% |
| 2017 | $15.50 | +42.9% |
Trading Range
The price is 10.9% above its 50-day average of $23.05 and 6.6% above its 200-day average of $23.97.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $25.56 | |
| 52-week high | $35.87 | -28.7% |
| 52-week low | $15.59 | +64.0% |
| 50-day average | $23.05 | +10.9% |
| 200-day average | $23.97 | +6.6% |
Price Risk
Over 3 years, its largest fall from a peak was 71.1%.
| Measure | Value |
|---|---|
| 1-year beta | 0.39 |
| Largest fall, 1 year | -42.8% |
| Largest fall, 3 years | -71.1% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About STAA
What is STAA's 1-year price change?
STAAR Surgical Company's price fell 2.9% over the past 12 months. With dividends included, the 12-month total return was -2.9%.
What is STAA's 5-year price change?
STAAR Surgical Company's month-end price fell 79.3% over the 5 years through Oct 2026, a compound annual decline of 27.0%. These figures leave out dividends.
What is STAA's 52-week high and low?
STAAR Surgical Company's 52-week high is $35.87 and its 52-week low is $15.59. Its latest price of $25.56 on Nov 17, 2026 is 28.7% below the high.
What is STAA's beta?
STAAR Surgical Company's 1-year beta against the S&P 500 is 0.39, so its price has moved less than the market over the past year. Its largest fall from a peak over the past year was 42.8%.
Is the STAA chart free?
Yes. Advanced Charting for STAA is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
STAA pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors, Government Contracts